Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Cash from Investing Activities (2010 - 2025)

Curis' (CRIS) quarterly Cash from Investing Activities came in at $2.5 million in Q4 2025, up 684.11% YoY from $318831.9 in Q4 2024, and up 684.11% on a QoQ basis from -$428000.0 in Q4 2024.

Curis (CRIS) Cash from Investing Activities (2010 - 2025) Analysis & Trends

Curis (CRIS) has 16 years of Cash from Investing Activities data on file, last reported at $2.5 million in Q4 2025.

  • Quarterly Cash from Investing Activities rose 684.11% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 76.26% YoY) and the FY2025 annual result came in at $2.5 million, down 91.51% from the prior year.
  • Cash from Investing Activities grew to $2.5 million in Q4 2025, from -$428000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $28.3 million in Q2 2022 to a low of -$28.8 million in Q2 2021.
  • A 5-year average of $3.2 million and a median of $180000.0 in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities plunged 11051.55% — and 2024, when it jumped 10076.67%.
  • Tracing CRIS's Cash from Investing Activities over 5 years: stood at -$3.5 million in 2021, then jumped by 198.3% to $3.5 million in 2022, then jumped by 319.2% to $14.5 million in 2023, then slumped by 102.95% to -$428000.0 in 2024, then surged by 684.11% to $2.5 million in 2025.
  • The last three Cash from Investing Activities figures came in at $2.5 million (Q4 2025), -$428000.0 (Q4 2024), and $18.3 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Curis 3.27 Mn -2.35 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.50 Mn
Dec 31, 2025 2.50 Mn
Dec 31, 2024 -428,000.00
Dec 31, 2024 -428,000.00
Sep 30, 2024 18.32 Mn
Sep 30, 2024 18.32 Mn
Jun 30, 2024 -7.36 Mn
Jun 30, 2024 -7.36 Mn
Mar 31, 2024 18.91 Mn
Mar 31, 2024 18.91 Mn
Dec 31, 2023 14.52 Mn
Dec 31, 2023 14.52 Mn
Sep 30, 2023 180,000.00
Sep 30, 2023 180,000.00
Jun 30, 2023 -3.15 Mn
Jun 30, 2023 -3.15 Mn
Mar 31, 2023 26.24 Mn
Mar 31, 2023 26.24 Mn
Dec 31, 2022 3.46 Mn
Dec 31, 2022 3.46 Mn